BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20933128)

  • 1. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
    Deng D; Liu Z; Du Y
    Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic applications of epigenetics.
    Miyamoto K; Ushijima T
    Jpn J Clin Oncol; 2005 Jun; 35(6):293-301. PubMed ID: 15930038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in ovarian cancer.
    Seeber LM; van Diest PJ
    Methods Mol Biol; 2012; 863():253-69. PubMed ID: 22359298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer epigenetics.
    Taby R; Issa JP
    CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNAs as molecular biomarkers of cancer.
    Fabbri M
    Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics and miRNAs in human cancer.
    Fabbri M; Calin GA
    Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG islands: their potential as biomarkers for cancer.
    Shi H; Wang MX; Caldwell CW
    Expert Rev Mol Diagn; 2007 Sep; 7(5):519-31. PubMed ID: 17892361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of DNA methylation markers for diagnosing cancer.
    Qureshi SA; Bashir MU; Yaqinuddin A
    Int J Surg; 2010; 8(3):194-8. PubMed ID: 20139036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic biomarkers in lung cancer.
    Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
    Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel methylation and expression markers associated with breast cancer].
    Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
    Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
    Wei J; Xie L; Taron M; Rosell R; Liu B
    Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epigenetic alterations in cancer].
    Toyota M; Suzuki H; Imai K; Shinomura Y
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2043-8. PubMed ID: 17471906
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer.
    Ellinger J; Müller SC; Stadler TC; Jung A; von Ruecker A; Bastian PJ
    Urol Oncol; 2011; 29(2):124-9. PubMed ID: 19762255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.